Articles by Disease (Non-melanoma Skin Cancer)

Nonviral Gene Therapy

Journal: Current Gene Therapy
Volume: 1
Page: 201-226
Author(s): Song Li and Zheng Ma

Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.

Journal: Current Pharmaceutical Design
Volume: 7
Page: 613-635
Author(s): Paul J. Kostenuik and victoria Shalhoub

Peptides as Carrier for Tumor Diagnosis and Treatment

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 1
Page: 71-93
Author(s): M. Langer and A. G. Beck-Sickinger

Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins

Journal: Current Pharmaceutical Biotechnology
Volume: 2
Page: 19-46
Author(s): Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter

The Mouse In Cancer Research Past, Present, Future

Journal: Current Genomics
Volume: 2
Page: 1-26
Author(s): K. Hunter and D. Cozma

The Use of TNF Family Ligands and Receptors and Agents which Modify their Interaction as Therapeutic Agents

Journal: Current Drug Targets
Volume: 1
Page: 327-364
Author(s): M. Gardnerova, R. Blanque and C. R. Gardner

Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer

Journal: Current Drug Targets
Volume: 1
Page: 163-183
Author(s): Charleata A. Carter

The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis

Journal: Current Pharmaceutical Biotechnology
Volume: 1
Page: 73-82
Author(s): Domenico Ribatti, Angelo Vacca, Luisa Roncali and Franco Dammacco

Vitamin D Analogs in Cutaneous Malignancies

Journal: Current Pharmaceutical Design
Volume: 6
Page: 829-838
Author(s): Slawomir Majewski, Andrzej Kutner and Stefania Jablonska

Journal: Current Pharmaceutical Design
Volume: 6
Page: 651-663
Author(s): Cory M. Hogaboam, Cynthia Bone-Larson, Akihiro Matsukawa, Matthew L. Steinhauser, Kate Blease, Nicholas W. Lukacs and Steven L. Kunkel